Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT03244072

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Conditions: Endophthalmitis

Sex: All
Ages: 40 Years – N/A
Healthy volunteers: Yes
Phase: PHASE2, PHASE3
Enrollment: 60000
Sponsor: Jason Ahee, M.D.

Location: Zion Eye Institute St. George Utah

Summary

Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis

Eligibility Criteria

Inclusion Criteria: * visually significant cataracts Exclusion Criteria: * allergy to fluoroquinolones, cobalamin (B12)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03244072). StuddyBuddy aggregates publicly available trial information.